QualityStocksNewsBreaks Archives - Page 1010 of 1628

TuesdayDec 22, 2020 12:58 pm

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Enters Agreement with Two Auto Companies to Revolutionize Buying, Leasing Experience

PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has joined forces with two other companies to revolutionize the auto-buying experience. The three companies — PowerBand, CB Auto Group Inc. and D&P Holdings Inc. — have entered into definitive agreements to provide millions of union and affinity group members with an unparalleled group buying power experience; the service, which is designed to provide information so members can be smarter auto shoppers, also allows them to purchase autos using their smartphones, tablets or computer. Beginning Q1 2021, PowerBand’s virtual transaction platform DRIVRZ(TM) website will be available to more than 70 million members of…

TuesdayDec 22, 2020 12:45 pm

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Completion of Patient Enrollment for Study of Cannabidiol Lotion for Eczema Treatment

Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products, has completed patient enrollment in its upcoming clinical study of JW-100, its proprietary cannabidiol lotion formulation for the treatment of atopic dermatitis, or eczema. The study is designed to investigate the efficacy and safety of JW-100. JUPW enrolled 66 patients for the multi-center, double-blinded, placebo-controlled trial. Study participants will be randomly selected to receive one of three topical formulations, including a placebo, at least twice daily. Data from the study is expected in Q1 2021. "We are eager to see the results of this trial,…

TuesdayDec 22, 2020 12:27 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Reaches Another Significant Milestone with Scaled-up Production of Clinical-Grade REQORSA(TM)

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced its completion of the manufacturing scale-up of REQORSA(TM) immunogene therapy. Subject to satisfactory completion of final testing currently underway, the clinical-grade production is intended to supply Genprex’s upcoming Acclaim-1 and Acclaim-2 clinical trials for the treatment of non-small cell lung cancer. The company recently announced the successful manufacturing technology transfer to commercial contract development and manufacturing organizations (“CDMOs”) as well as the successful engineering run of REQORSA, which passed all testing specifications. “The scaled-up production of clinical-grade REQORSA is yet another significant manufacturing milestone…

TuesdayDec 22, 2020 12:16 pm

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Applauds Bipartisan Appropriation of Funds for US Uranium Reserve

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium miner in the U.S., applauds the bipartisan, bicameral launch of the U.S. uranium reserve, as $75 million of funding was included in the omnibus appropriation bill. The bill, passed last night by both houses of Congress, is expected to be sent to the President for signature in the coming days. One of the main recommendations of the U.S. Nuclear Fuel Working Group, directed to make recommendations on securing the domestic capacity to produce uranium and nuclear fuel, was to appropriate funding for a U.S. uranium reserve. This key funding opens…

TuesdayDec 22, 2020 12:07 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moving Forward with Clinical Trials in 2021 after Receiving FDA Approval for IND for Berubicin

The company is scheduled to conduct three clinical trials in 2021 for Berubicin – two Phase II and the first-ever Phase I in pediatric patients FDA modified the trial design to designate overall survival as the trial’s primary endpoint The market for brain tumor therapies is expected to grow at a CAGR of 10% and reach an estimated $1.6 billion in 2025 CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, announced that it obtained the Food and Drug Administration’s Investigational New Drug…

TuesdayDec 22, 2020 11:41 am

QualityStocksNewsBreaks – Knightscope Inc. Announces Launch of Its Public Safety App

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced the availability of a new app designed to involve the community to assist in reimagining public safety. According to the update, the Knightscope Public Safety App is now available in both the App Store and Google Play. “Anyone can download the app and take a video of a place where they think an Autonomous Security Robot will contribute to public safety,” the Knightscope update reads. “Record your video, enter some basic information about the location and submit. We'll take it from there. Head on…

TuesdayDec 22, 2020 11:18 am

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Category Leading Sales Growth, Significant Expansion in Disposable E-Cig Market Share

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of products manufactured by Bidi Vapor LLC. Bidi Vapor's primary offering, the Bidi (TM) Stick, is the fastest-growing closed system vaping product in the U.S. and also the market’s only vape product with an ecologically friendly, mass-recycling program. Kaival Brands today announced that, based on Goldman Sachs' Equity Research Report through Nov. 28, 2020, on the Nielsen data for total nicotine volumes (the "Goldman Report"), the Bidi (TM) Stick is now the second largest disposable…

TuesdayDec 22, 2020 11:13 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) CEO Talks Benefits of Disposable Brain Diagnostic Tools

Brain Scientific (OTCQB: BRSF) co-founder and CEO Boris Goldstein penned a recent article for “Healthcare” magazine. Titled “Brain Scientific: Neurology’s need for disposable solutions,” the article provides an overview of the need for new devices in the neurology market and the advantages of disposable brain diagnostic tools. Goldstein noted that his interest in brain diagnostic tools began when he was studying at college, where he used clustering analysis for Rorschach testing. As the founder of BrainRX, he was involved in pre-Alzheimer diagnostic and software development, and he was always searching for places to obtain data for artificial analysis or data correlation.…

TuesdayDec 22, 2020 10:51 am

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Dramatic Results of Fuel4Thought(TM) Migraine Formula Pilot Study

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM) (“UBN”) has reported the successful completion of a pilot study for its proprietary Fuel4Thought(TM) (F4T(TM)) formulation to help with migraines. “We were excited to study this unique F4T(TM) formulation, as previous scientific data had indicated that this combination of natural ingredients could have a positive benefit for migraines,” said Dr. Gerald Haase, MD, a key consultant to the GRCK Medical Advisory Board.…

TuesdayDec 22, 2020 10:29 am

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Finalizes Agreement to Provide RPM Solution to Presbyterian Medical Services

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has inked an agreement with one of the largest integrated healthcare systems in the state of New Mexico to provide remote patient monitoring (“RPM”). The partnership with Presbyterian Medical Services begins Jan. 1, 2021. The agreement, which followed a rigorous request for proposal (“RFP”) process, reflects DRIO’s shift in focus to B2B2C and outlines the company’s commitment to provide access to Dario's next-generation, AI-powered digital therapeutics tools and quality care to patients living with chronic conditions, such as diabetes and hypertension. "We are very pleased to partner with Presbyterian Medical Services in…

Site Search

Company Search

Category: QualityStocksNewsBreaks